Related Experiment Video
Updated: Jun 6, 2025

Preparation of Polyoxometalate-based Photo-responsive Membranes for the Photo-activation of Manganese Oxide Catalysts
Published on: August 7, 2018
Facile construction of polyoxometalate-polymer hybrid nanoparticles with pH/redox dual-responsiveness
Yanting Gao1,2, Fan Yang1, Yufu Wang1
1School of Chemistry, The University of Melbourne Parkville 3010 Victoria Australia gsuch@unimelb.edu.au.
Abstract:
Responsive nanomaterials have emerged as promising candidates for advanced drug delivery systems (DDSs), offering the potential to precisely target disease sites and enhance treatment efficacy. To fulfil their potential, such materials need to be engineered to respond to specific variations in biological conditions. In this work, we present a series of pH/redox dual-responsive hybrid nanoparticles featuring an amphiphilic shell polymer and a pH-responsive core polymer. These nanoparticles incorporate a polyoxometalate (POM), specifically the cobalt(iii)-substituted borotungstate ([BIIIW11O39CoIII]6-), loaded through coordination chemistry between the encapsulated CoIII ions of the POM and pyridyl functional groups on the core polymer. The resulting hybrid nanoparticles show potential for controlled release with excellent stability at physiological pH, and efficient particle disassembly in response to the combination of pH and redox stimuli. Disassembly is proposed to occur following a two step mechanism. Structural rearrangement of the nanoparticle occurs on acidification followed by destabilization of the coordination bond between the polyanion and the pyridyl functionality in the core polymer following reduction. In this system, the POM acts in a novel role as a redox active structural cross-linker. These hybrid dual-responsive nanoparticles, featuring superior colloidal stability under extracellular conditions and controllable disintegration in response to the dual stimuli of acidic pH and redox conditions, provide a novel platform for the controlled intracellular release of therapeutics.

